94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Hematol.
Sec. Immunobiology and Immunotherapy
Volume 4 - 2025 | doi: 10.3389/frhem.2025.1547209
Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
Provisionally accepted
Asis Shrestha 1,2
Anup Kumar Trikannad Ashwini Kumar 1,2
Soumya Pandey 2,3 Tanvi Patel 1,2 Hira Imad Cheema 1,2 Syed Mujtaba Naqvi 1,2 Ramya Bachu 1,2 Trilok Shrivastava 1,2 Sharmilan Thanendrarajan 1,2
Maurizio Zangari 1,2 Samer Al Hadidi 1,2
Frits van Rhee 1,2
Carolina Schinke 1,2*- 1 Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, United States
- 2 University of Arkansas for Medical Sciences, Little Rock, United States
- 3 Department of Pathology, College of Medicine, Little Rock, United States
No abstract for case report
Keywords: immune thrombocytopenia1, teclistamab2, BCMA3, Multiple Myeloma4, plasma cells5
Received: 17 Dec 2024; Accepted: 28 Mar 2025.
Copyright: © 2025 Shrestha, Trikannad Ashwini Kumar, Pandey, Patel, Cheema, Naqvi, Bachu, Shrivastava, Thanendrarajan, Zangari, Al Hadidi, van Rhee and Schinke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Carolina Schinke, Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.